Metraipolis › archive › dc_02bfcfe4e79d

Gemcitabine-Based Bladder Preservation in BCG-Unresponsive High-Risk NMIBC: Evidence, Limitations, and Clinical Positioning — Europe PMC PMID:42652203

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42652203
DOI: 10.3390/biomedicines14081821
License (as archived): solo-consultazione
Archived: 2026-10-16T15:55:53.086Z
SHA-256 of the archived text: 8f283f159ced1cb763111d22075a90ae66ce04ac82927622a7b1028ad84e10e8
Stable URL of this page: https://metraipolis.com/documento/dc_02bfcfe4e79d

How to cite

Gemcitabine-Based Bladder Preservation in BCG-Unresponsive High-Risk NMIBC: Evidence, Limitations, and Clinical Positioning — Europe PMC PMID:42652203 — Europe PMC (en), https://europepmc.org/article/MED/42652203 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_02bfcfe4e79d (Metraipolis archive dc_02bfcfe4e79d, sha256 8f283f159ced1cb763111d22075a90ae66ce04ac82927622a7b1028ad84e10e8)

BibTeX

@misc{dc02bfcfe4e79d,
  title = {Gemcitabine-Based Bladder Preservation in BCG-Unresponsive High-Risk NMIBC: Evidence, Limitations, and Clinical Positioning — Europe PMC PMID:42652203},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42652203},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_02bfcfe4e79d; sha256 8f283f159ced1cb763111d22075a90ae66ce04ac82927622a7b1028ad84e10e8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42652203. Agents can read the archived copy with the MCP tool read_document.